Track Record of Identifying Rare Wealth Creators

Blogs

May 16, 2026
Infographic style Hero Showing Four Investor Mindsets Lucky left Gray Confused left Light Gray Disciplined Investor right Green and Bias trapped right Orange

Myopic Loss Aversion (Benartzi & Thaler 1995): Why Indian Retail Investors Sabotage Long-Term Returns by Checking Portfolios Too Often

Myopic Loss Aversion — Benartzi & Thaler's 1995 Nobel-grade explanation of the equity premium puzzle, applied to Indian retail investors, with Titan Biotech FY25 audited numbers as an anti-MLA corporate-cadence case study.
May 16, 2026
Hero Header Net Debt to Ebitda Ratio with a Green Accent multibagger Shares and a Subtitle Line on a Dark Blue Background

Net Debt to EBITDA Ratio: The Single Solvency Test Credit Analysts Care About Most

Net Debt to EBITDA is the single ratio professional credit analysts use most when assessing survival odds. This educational deep-dive teaches how to read it, where retail investors misinterpret it, and how Titan Biotech (BSE: 524717) FY25 audited numbers illustrate a -0.75x net-cash fortress reading. Not a buy/sell recommendation.
May 16, 2026
Hero Section with Title look through Earnings over a Dark Blue Gradient Subtitle Text and a Centered Multicolor Donut Chart Labeled fy25 Reinvested

Look-Through Earnings: Warren Buffett’s 1990 Berkshire Letter Framework for Measuring Your True Portfolio Earnings

Warren Buffett's 1990 Berkshire letter introduced look-through earnings — dividends plus your proportional share of retained profits. Why this single number reveals what your portfolio truly earned, illustrated by Titan Biotech FY25's high-retention, low-debt capex discipline.
May 15, 2026
Hero Section with the Title ambiguity Aversion and Subtitle a 2x2 Color Grid Showing lucky gray disciplined Investor green confused light Gray and bias trapped orange Against a Dark Blue Background

Ambiguity Aversion: Daniel Ellsberg’s 1961 Paradox and Why Indian Investors Prefer the Illusion of Probabilistic Certainty in Weekly Options Over the Honest Uncertainty of Long-Term Equity

Daniel Ellsberg's 1961 paradox shows humans pay a premium to avoid unknown probabilities, not just risk. This explains the bulk of Indian F&O loss data, sub-5-month equity holding periods and month-21 SIP abandonment. Titan Biotech FY25's disclosure architecture is read as a positive illustration of how a small-cap can collapse ambiguity for long-term investors. Educational case study only — no buy/sell call.
+91-8448836436